当前位置:首页 - 行情中心 - 奥翔药业(603229) - 财务分析

奥翔药业

(603229)

  

流通市值:80.87亿  总市值:80.87亿
流通股本:8.30亿   总股本:8.30亿

奥翔药业(603229)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润2.07亿元,每股收益0.25元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益234730.06万元,未分配利润99772.20万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产306035.39万元,负债71305.33万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入645,961,585.61481,872,188.3306,636,220.57795,288,308.9
营业总成本436,884,971.86302,198,297.13169,849,438.7575,480,342.93
其他经营收益
营业利润234,233,339.74195,436,252.9136,769,869.82241,143,575.95
利润总额233,345,728.07194,677,453.13136,732,467.33240,200,048.65
净利润207,031,905.94169,346,106.65119,199,188.77206,791,017.22
每股收益
其他综合收益19,962.489,445.84670,246.5329,582.57
综合收益总额207,051,868.42169,355,552.49119,869,435.3206,820,599.79
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计1,793,706,183.581,861,691,662.71,836,403,912.681,709,169,547.87
非流动资产:
非流动资产合计1,266,647,706.631,273,369,390.871,284,154,799.931,273,220,502.52
资产总计3,060,353,890.213,135,061,053.573,120,558,712.612,982,390,050.39
流动负债:
流动负债合计631,624,715.86656,893,917.84714,430,201.79674,525,715.76
非流动负债:
非流动负债合计81,428,542.3252,457,685.0234,354,931.3335,973,131.92
负债合计713,053,258.18709,351,602.86748,785,133.12710,498,847.68
所有者权益(或股东权益):
归属于母公司股东权益合计2,347,300,632.032,425,709,450.712,371,773,579.492,271,891,202.71
股东权益合计2,347,300,632.032,425,709,450.712,371,773,579.492,271,891,202.71
负债和股东权益合计3,060,353,890.213,135,061,053.573,120,558,712.612,982,390,050.39
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计720,011,893.88436,663,112.49260,035,698.68853,563,748.87
经营活动现金流出小计572,366,281.51391,259,445.69257,989,311.38675,637,971.51
经营活动产生的现金流量净额147,645,612.3745,403,666.82,046,387.3177,925,777.36
投资活动产生的现金流量:
投资活动现金流入小计48,088,170.7739,477,425.085,947,942.7237,602,044.94
投资活动现金流出小计95,925,955.1767,801,763.7136,820,547.22157,570,981.97
投资活动产生的现金流量净额-47,837,784.4-28,324,338.63-30,872,604.5-119,968,937.03
筹资活动产生的现金流量:
筹资活动现金流入小计307,896,522.55246,589,792.7989,790,810.84290,812,726.52
筹资活动现金流出小计373,013,518.93242,733,760.37104,874,200.35399,032,612.08
筹资活动产生的现金流量净额-65,116,996.383,856,032.42-15,083,389.51-108,219,885.56
汇率变动对现金及现金等价物的影响-2,547,447.625,776,044.163,875,717.8110,842,676.45
现金及现金等价物净增加额32,143,383.9726,711,404.75-40,033,888.9-39,420,368.78
期末现金及现金等价物余额1,080,724,603.121,075,292,623.91,008,547,330.251,048,581,219.15
补充资料:
现金及现金等价物的净增加额-26,711,404.75--39,420,368.78
最新报告期:2025-11-03
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信证券陈竹,王凯旋0.280.330.402025-11-03
太平洋周豫,乔露阳0.290.350.462025-10-30
中泰证券祝嘉琦0.250.300.352025-10-01
TOP↑